BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
11 results:

  • 1. FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of epa and DHA in vitro treatments.
    Belloni A; Notarstefano V; Greco S; Pellegrino P; Giorgini E; Ciarmela P
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166873. PubMed ID: 37666437
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protective effect of eicosapentaenoic acid against estradiol valerate-induced endometrial hyperplasia via modulation of NF-κB/HIF-1α/VEGF signaling pathway in rats.
    Abdelzaher WY; Ibrahim MA; Hassan M; El-Tahawy NFG; Fawzy MA; Hafez HM
    Chem Biol Interact; 2023 Mar; 373():110399. PubMed ID: 36774993
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Delayed cervical cancer diagnosis: a systematic review.
    Allahqoli L; Dehdari T; Rahmani A; Fallahi A; Gharacheh M; Hajinasab N; Salehiniya H; Alkatout I
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8467-8480. PubMed ID: 36459029
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metalloproteinases in Endometrial cancer-Are They Worth Measuring?
    Michalczyk K; Cymbaluk-Płoska A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830354
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, timp-1, timp-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
    BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasma Levels and Tissue Expression of Selected Cytokines, Metalloproteinases and Tissue Inhibitors in Patients With Cervical cancer.
    Sidorkiewicz I; Piskór B; Dąbrowska E; Guzińska-Ustymowicz K; Pryczynicz A; Zbucka-Krętowska M; Ławicki S
    Anticancer Res; 2019 Nov; 39(11):6403-6412. PubMed ID: 31704874
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical cancer Based on ROC Analysis.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
    Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Interstitial collagenase and their endogenous regulators in squamous cell cervical carcinoma].
    Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Solovyeva NI
    Biomed Khim; 2017 Nov; 63(6):513-519. PubMed ID: 29251612
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High serum timp-1 is associated with adverse prognosis in endometrial carcinoma.
    Honkavuori M; Talvensaari-Mattila A; Puistola U; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2008; 28(5A):2715-9. PubMed ID: 19035300
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
    Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
    Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.